From: Histopathological findings in a COVID-19 patient affected by ischemic gangrenous cholecystitis
 | Normal range | Day 0 | Day 3 | Day 6 | Day 9 | Day 12 | Day 15 | Day 18 | Day 21 |
---|---|---|---|---|---|---|---|---|---|
White blood cell (n/ÎĽL) | 4.5-11 | 23.8 | 21.00 | 24.00 | 14.00 | 12.78 | 31.05 | 57.35 | 16.36 |
Neutrophils (%) | 45-62 | 85.2 | 81.9 | 85.3 | 79.5 | 15.3 | 77.8 | 86.4 | 69.1 |
Lymphocytes (%) | 16-33 | 7 | 10.7 | 7.7 | 10.6 | 12.8 | 11.2 | 7.8 | 14.8 |
Platelets (n Ă— 103/ÎĽL) | 150-400 | 118 | 193 | 220 | 139 | 136 | 150 | 169 | 163 |
Procalcitonin (ng/mL) | < 0.2 | 0.87 | 0.31 | 0.28 | 0.19 | 0.20 | 0.27 | 2.45 | 1.07 |
Troponin (ng/L) | < 14 | 30 | 20 | 25.4 | 48.2 | 48.1 | 42.7 | 94.2 | 96.6 |
Myoglobin (ng/mL) | 25-72 | 93 | 486 | 266 | 426 | 274 | 173 | 368 | 224 |
CK-Mb (ng/mL) | < 3.61 | 1.4 | 1.2 | 1.2 | 1.2 | 2.4 | 1.2 | 4.4 | 5.2 |
Lactate dehydrogenase (IU/L) | < 600 | 1560 | 1160 | 804 | 407 | 620 | 755 | 816 | 696 |
Creatinine (mg/dL) | 0.8-1.2 | 2.27 | 2.12 | 2.29 | 2.12 | 2.19 | 2.66 | 3.18 | 3.4 |
Alanine aminotransferase (IU/L) | ≤ 34 | 146 | 52 | 58 | 38 | 59 | 45 | 43 | 34 |
Aspartate aminotransferase (IU/L) | ≤ 34 | 74 | 78 | 86 | 50 | 49 | 51 | 30 | 28 |
Total bilirubin (mg/dL) | < 1.40 | 1.10 | 0.92 | 1.14 | 1 | 1.43 | 1.20 | 0.63 | 0.42 |
Conjugated bilirubin (mg/dL) | < 0.40 | 1.09 | 0.69 | 0.66 | 0.64 | 0.83 | 0.63 | 0.40 | 0.28 |